Complex Rhythm Management: A Review of 2023 Guidelines on Atrial Fibrillation Management

Activity Summary

Atrial fibrillation (AF) is the most common type of sustained cardiac arrythmia, affecting an estimated 2% to 3% of the population globally. Although lifestyle and risk modifications are the mainstay of management for prevention and progression, APRNs must be prepared to utilize a shared decision-making framework when applying the 2023 guidelines related to use of antiarrhythmic and anticoagulation therapy. For patients who fail rhythm control or for whom anticoagulant therapy cannot be tolerated, APRNs should understand the nuances associated with interventional therapies. Pharmacology content = 20%

Objectives

Discuss antiarrhythmic therapy utilized to maintain sinus rhythm.
Review indications and side effects of anticoagulation therapy, with review of validated clinical risk scores.
Identify patient eligibility for ablation therapy and/or left atrial appendage closure.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.